Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Havjin Jacob"'
Autor:
Havjin Jacob, Luka Stanisavljevic, Kristian Eeg Storli, Kjersti E. Hestetun, Olav Dahl, Mette P. Myklebust
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Abstract About 20 percent of TNM-stage II colon cancer patients who are treated by surgical resection develop recurrence, and adjuvant chemotherapy in this group is still debated among researchers and clinicians. Currently, adverse histopathological
Externí odkaz:
https://doaj.org/article/9dd3caffa57b43dc8719f849893eb89b
Autor:
Sigmund Ytre-Hauge, Kristine Eldevik Fasmer, Julie Andrea Dybvik, Havjin Jacob, Camilla Krakstad, Jone Trovik, Erling A. Hoivik, Ingfrid S. Haldorsen
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 3
Journal of Clinical Medicine, Vol 10, Iss 538, p 538 (2021)
Volume 10
Issue 3
Journal of Clinical Medicine, Vol 10, Iss 538, p 538 (2021)
Integrative tumor characterization linking radiomic profiles to corresponding gene expression profiles has the potential to identify specific genetic alterations based on non-invasive radiomic profiling in cancer. The aim of this study was to develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88b9ddec877d4fed97b777137ba30698
https://hdl.handle.net/11250/2787023
https://hdl.handle.net/11250/2787023
Autor:
Camilla Krakstad, Kristine Eldevik Fasmer, Bert Delvoux, Mari K. Halle, Ingvild L. Tangen, Elin Strand, Havjin Jacob, Erling A. Hoivik, Andrea Romano, Ingfrid S. Haldorsen, Jone Trovik
Publikováno v:
Metabolites; Volume 9; Issue 12; Pages: 302
Metabolites
Metabolites, 9(12):302. Multidisciplinary Digital Publishing Institute (MDPI)
Metabolites
Metabolites, 9(12):302. Multidisciplinary Digital Publishing Institute (MDPI)
Endometrial cancer has a high prevalence among post-menopausal women in developed countries. We aimed to explore whether certain metabolic patterns could be related to the characteristics of aggressive disease and poorer survival among endometrial ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab787e669a1f0cefec0ebdd0b1295931
Autor:
Kjersti E. Hestetun, Luka Stanisavljevic, Kristian Eeg Storli, Mette Pernille Myklebust, Havjin Jacob, Olav Dahl
Publikováno v:
Oncotarget
// Havjin Jacob 1 , Luka Stanisavljevic 2 , Kristian Eeg Storli 3 , Kjersti E. Hestetun 1 , Olav Dahl 1, 2 and Mette P. Myklebust 2 1 Department of Clinical Science, Faculty of Medicine, University of Bergen, Bergen, Norway 2 Department of Oncology a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ed3cb2068c066c4e6f1cd6b19315f4
https://doi.org/10.18632/oncotarget.21237
https://doi.org/10.18632/oncotarget.21237
Autor:
Mette Pernille Myklebust, Olav Dahl, Kristian Eeg Storli, Luka Stanisavljevic, Kjersti E. Hestetun, Havjin Jacob
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-9 (2018)
About 20 percent of TNM-stage II colon cancer patients who are treated by surgical resection develop recurrence, and adjuvant chemotherapy in this group is still debated among researchers and clinicians. Currently, adverse histopathological and clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40ad8de0266b71add3f9e6afc901d8dc
https://doi.org/10.1038/s41598-018-24519-4
https://doi.org/10.1038/s41598-018-24519-4
Autor:
Kjetil Boye, Olav Dahl, Havjin Jacob, Jahn M. Nesland, Kari Anne Myrum Frikstad, Gunhild Mari Mælandsmo, Arild Nesbakken, Kjersti Flatmark
Publikováno v:
Cancer Medicine
Published version. Source at http://dx.doi.org/10.1002/cam4.766 Current clinical algorithms are unable to precisely predict which colorectal cancer patients would benefit from adjuvant chemotherapy, and there is a need for novel biomarkers to improve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f43ba2337910bc425940c2b7f07b64d3
https://hdl.handle.net/10037/10549
https://hdl.handle.net/10037/10549
Publikováno v:
Cancer Research. 77:469-469
Background: Colon cancer is one of the most common cancers with increasing incidence and high mortality worldwide. Prognosis and choice of treatment is largely based on the tumor stage at presentation. Thus, finding novel biomarkers for predicting su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa6fd7edd8922fe1fe60282476a00f2c
https://doi.org/10.1158/1538-7445.am2017-469
https://doi.org/10.1158/1538-7445.am2017-469
Publikováno v:
Journal of Clinical Oncology. 33:e14503-e14503
e14503 Background: β-catenin and plakoglobin are members of the catenin protein family and localize to adherens junctions and desmosomes, respectively. In this study, we evaluated the prognostic va...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9f6b985c3113a41c9afbca67b1e05c7d
https://doi.org/10.1200/jco.2015.33.15_suppl.e14503
https://doi.org/10.1200/jco.2015.33.15_suppl.e14503